These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 18421273)

  • 1. Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program.
    West DS; Elaine Prewitt T; Bursac Z; Felix HC
    Obesity (Silver Spring); 2008 Jun; 16(6):1413-20. PubMed ID: 18421273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight Loss Experiences of African American, Hispanic, and Non-Hispanic White Men and Women with Type 2 Diabetes: The Look AHEAD Trial.
    West DS; Dutton G; Delahanty LM; Hazuda HP; Rickman AD; Knowler WC; Vitolins MZ; Neiberg RH; Peters A; Gee M; Cassidy Begay M;
    Obesity (Silver Spring); 2019 Aug; 27(8):1275-1284. PubMed ID: 31338998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormone binding globulin and sex steroids among premenopausal women in the diabetes prevention program.
    Kim C; Pi-Sunyer X; Barrett-Connor E; Stentz FB; Murphy MB; Kong S; Nan B; Kitabchi AE;
    J Clin Endocrinol Metab; 2013 Jul; 98(7):3049-57. PubMed ID: 23709655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.
    The Diabetes Prevention Program Research Group
    Diabetes Care; 2000 Nov; 23(11):1619-29. PubMed ID: 11092283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
    ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
    Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of biphasic insulin aspart 70/30 in type 2 diabetes patients of different race or ethnicity (INITIATEplus trial).
    Trippe BS; Shepherd MD; Coulter FC; Bhargava A; Brett J; Chu PL; Oyer DS
    Curr Med Res Opin; 2012 Jul; 28(7):1203-11. PubMed ID: 22509859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of long-term weight loss in adults with modest initial weight loss, by sex and race.
    Svetkey LP; Ard JD; Stevens VJ; Loria CM; Young DY; Hollis JF; Appel LJ; Brantley PJ; Kennedy BM; Kumanyika SK; Batch BC; Corsino L; Lien LF; Vollmer WM;
    Obesity (Silver Spring); 2012 Sep; 20(9):1820-8. PubMed ID: 21527896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of lifestyle and metformin interventions in DPP on bone density.
    Schwartz AV; Pan Q; Aroda VR; Crandall JP; Kriska A; Piromalli C; Wallia A; Temprosa M; Florez H;
    Osteoporos Int; 2021 Nov; 32(11):2279-2287. PubMed ID: 34086101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study.
    Luchsinger JA; Ma Y; Christophi CA; Florez H; Golden SH; Hazuda H; Crandall J; Venditti E; Watson K; Jeffries S; Manly JJ; Pi-Sunyer FX;
    Diabetes Care; 2017 Jul; 40(7):958-965. PubMed ID: 28500216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Sociodemographic factors on goal achievement in a community-based diabetes prevention program behavioral lifestyle intervention.
    Devaraj SM; Napoleone JM; Miller RG; Rockette-Wagner B; Arena VC; Mitchell-Miland C; Saad MB; Kriska AM
    BMC Public Health; 2021 Oct; 21(1):1783. PubMed ID: 34600527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender and racial/ethnic background predict weight loss after Roux-en-Y gastric bypass independent of health and lifestyle behaviors.
    Coleman KJ; Brookey J
    Obes Surg; 2014 Oct; 24(10):1729-36. PubMed ID: 24802770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic responses of insulin degludec in African American, white, and Hispanic/Latino patients with type 2 diabetes mellitus.
    Hompesch M; Morrow L; Watkins E; Roepstorff C; Thomsen HF; Haahr H
    Clin Ther; 2014 Apr; 36(4):507-15. PubMed ID: 24508419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body size and shape changes and the risk of diabetes in the diabetes prevention program.
    Fujimoto WY; Jablonski KA; Bray GA; Kriska A; Barrett-Connor E; Haffner S; Hanson R; Hill JO; Hubbard V; Stamm E; Pi-Sunyer FX;
    Diabetes; 2007 Jun; 56(6):1680-5. PubMed ID: 17363740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.
    Diabetes Prevention Program Research Group
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):866-75. PubMed ID: 26377054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.
    Goldberg RB; Temprosa M; Mele L; Orchard T; Mather K; Bray G; Horton E; Kitabchi A; Krakoff J; Marcovina S; Perreault L; White N;
    Metabolism; 2016 May; 65(5):764-775. PubMed ID: 27085783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.
    Apolzan JW; Venditti EM; Edelstein SL; Knowler WC; Dabelea D; Boyko EJ; Pi-Sunyer X; Kalyani RR; Franks PW; Srikanthan P; Gadde KM;
    Ann Intern Med; 2019 May; 170(10):682-690. PubMed ID: 31009939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Weight Loss by Race and Ethnicity in the PRIDE Trial: a Qualitative Analysis of Participant Perspectives.
    Saju R; Castellon-Lopez Y; Turk N; Moin T; Mangione CM; Norris KC; Vu A; Maranon R; Fu J; Cheng F; Duru OK
    J Gen Intern Med; 2022 Nov; 37(14):3715-3722. PubMed ID: 35469358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
    Knowler WC; Barrett-Connor E; Fowler SE; Hamman RF; Lachin JM; Walker EA; Nathan DM;
    N Engl J Med; 2002 Feb; 346(6):393-403. PubMed ID: 11832527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation.
    Herman WH; Pan Q; Edelstein SL; Mather KJ; Perreault L; Barrett-Connor E; Dabelea DM; Horton E; Kahn SE; Knowler WC; Lorenzo C; Pi-Sunyer X; Venditti E; Ye W;
    Diabetes Care; 2017 Dec; 40(12):1668-1677. PubMed ID: 29021207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.